Fmr LLC increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 26.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,775,451 shares of the company’s stock after acquiring an additional 580,449 shares during the period. Fmr LLC owned approximately 3.16% of Acadia Healthcare worth $137,052,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in ACHC. BlackRock Inc. grew its holdings in Acadia Healthcare by 27,497.3% during the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after acquiring an additional 5,127,140 shares during the period. Aristotle Capital Management LLC acquired a new position in Acadia Healthcare during the first quarter worth about $140,071,000. William Blair Investment Management LLC grew its holdings in Acadia Healthcare by 1,247.4% during the second quarter. William Blair Investment Management LLC now owns 2,128,972 shares of the company’s stock worth $105,129,000 after acquiring an additional 1,970,965 shares during the period. Point72 Asset Management L.P. grew its holdings in Acadia Healthcare by 143.4% during the first quarter. Point72 Asset Management L.P. now owns 1,085,000 shares of the company’s stock worth $47,306,000 after acquiring an additional 639,300 shares during the period. Finally, Rice Hall James & Associates LLC acquired a new position in Acadia Healthcare during the second quarter worth about $30,151,000.

In other Acadia Healthcare news, President Brent Turner sold 206,252 shares of the stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $10,454,913.88. Following the completion of the sale, the president now directly owns 81,106 shares in the company, valued at $4,111,263.14. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Christopher L. Howard sold 16,762 shares of the stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $52.47, for a total value of $879,502.14. Following the completion of the sale, the executive vice president now owns 200,999 shares of the company’s stock, valued at $10,546,417.53. The disclosure for this sale can be found here. Insiders sold 3,085,693 shares of company stock valued at $157,729,099 over the last 90 days. Corporate insiders own 11.10% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Acadia Healthcare Company, Inc. (ACHC) Shares Bought by Fmr LLC” was first posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://www.watchlistnews.com/acadia-healthcare-company-inc-achc-shares-bought-by-fmr-llc/1614774.html.

A number of research analysts recently issued reports on ACHC shares. William Blair started coverage on Acadia Healthcare in a report on Tuesday, July 18th. They set an “outperform” rating on the stock. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 1st. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, October 2nd. Craig Hallum reaffirmed a “buy” rating and set a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Finally, Deutsche Bank AG lifted their target price on Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, July 31st. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Acadia Healthcare presently has a consensus rating of “Buy” and an average price target of $56.90.

Shares of Acadia Healthcare Company, Inc. (ACHC) opened at 45.63 on Friday. The firm has a market capitalization of $4.01 billion, a price-to-earnings ratio of 501.43 and a beta of 1.07. Acadia Healthcare Company, Inc. has a 12 month low of $32.54 and a 12 month high of $54.34. The firm’s 50-day moving average price is $46.66 and its 200-day moving average price is $46.25.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. During the same period in the prior year, the company earned $0.73 earnings per share. The company’s revenue for the quarter was down 5.4% compared to the same quarter last year. On average, equities analysts anticipate that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.